| 246 |
Inokosterone
|
-
Inokosterone, CAS-RN: 15130-85-5, DTXSID40164756
|
4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
|
| 247 |
Ecdysone
|
|
4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
|
| 251 |
TCPOBOP
|
|
107: Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat
|
| 253 |
UV-activated Titanium dioxide nanoparticles
|
|
208: Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure
|
| 257 |
Polybrominated diphenyl ethers
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 258 |
Isoflavones
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 259 |
Perflourinated chemicals
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 260 |
Phthalates
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 262 |
Clonixin
|
-
Clonixin, CAS-RN: 17737-65-4, DTXSID2046121
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 263 |
Meclofenamic acid
|
-
Meclofenamic acid, CAS-RN: 644-62-2, DTXSID0048559
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 264 |
2,6-dinitro-p-cresol
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 265 |
Triclopyr
|
-
Triclopyr, CAS-RN: 55335-06-3, DTXSID0032497
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 267 |
5alpha-Dihydrotestosterone
|
-
5alpha-Dihydrotestosterone, CAS-RN: 521-18-6, DTXSID9022364
|
376: Androgen receptor agonism leading to male-biased sex ratio
|
| 271 |
Mental stress
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|
| 275 |
NonSteroidal Anti-Inflammatory Drugs (NSAID)
|
|
217: Gastric ulcer formation
|
| 276 |
Helicobacter pylori
|
|
217: Gastric ulcer formation
|
| 279 |
Bioflavonoids
|
|
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 281 |
etoposide quinone
|
|
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 296 |
>85 known Cyp2E1 substrates
|
|
220: Cyp2E1 Activation Leading to Liver Cancer
|
| 297 |
NSAID (Nonsteroidal anti-inflammatory drug) inhibits PTGS1
|
|
227: NSAID induced PTGS1 inactivation to gastric ulcer
|
| 298 |
NSAID (Nonsteroidal anti-inflammatory drug) inhibits PTGS2
|
|
228: NSAID induced PTGS2 inactivation to gastric ulcer
|
| 299 |
Helicobacter pylori infection
|
|
229: Helicobacter pylori to gastric ulcer
|
| 301 |
NFE2/Nrf2 repression
|
|
232: NFE2/Nrf2 repression to steatosis
|
| 305 |
Single walled carbon nanotubes
|
|
409: Frustrated phagocytosis leads to malignant mesothelioma
|
| 306 |
Multi-walled carbon nanotubes
|
|
409: Frustrated phagocytosis leads to malignant mesothelioma
|